Citations to this article
Abstract
Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mount a humoral immune response to the virus within a few weeks of infection, but the duration of this response and how it correlates with clinical outcomes has not been completely characterized. Of particular importance is the identification of immune correlates of infection that would support public health decision-making on treatment approaches, vaccination strategies, and convalescent plasma therapy. While ELISA-based assays to detect and quantitate antibodies to SARS-CoV-2 in patient samples have been developed, the detection of neutralizing antibodies typically requires more demanding cell-based viral assays. Here, we present a safe and efficient protein-based assay for the detection of serum and plasma antibodies that block the interaction of the SARS-CoV-2 spike protein receptor binding domain (RBD) with its receptor, angiotensin-converting enzyme 2 (ACE2). The assay serves as a surrogate neutralization assay and is performed on the same platform and in parallel with an ELISA for the detection of antibodies against the RBD, enabling a direct comparison. The results obtained with our assay correlate with those of 2 viral-based assays, a plaque reduction neutralization test (PRNT) that uses live SARS-CoV-2 virus and a spike pseudotyped viral vector–based assay.
Authors
Kento T. Abe, Zhijie Li, Reuben Samson, Payman Samavarchi-Tehrani, Emelissa J. Valcourt, Heidi Wood, Patrick Budylowski, Alan P. Dupuis II, Roxie C. Girardin, Bhavisha Rathod, Jenny H. Wang, Miriam Barrios-Rodiles, Karen Colwill, Allison J. McGeer, Samira Mubareka, Jennifer L. Gommerman, Yves Durocher, Mario Ostrowski, Kathleen A. McDonough, Michael A. Drebot, Steven J. Drews, James M. Rini, Anne-Claude Gingras
Citation information
Citations to this article (154)
| Title and authors | Publication | Year |
|---|---|---|
|
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models
Naghibosadat M, Babuadze GG, Pei Y, Hurst J, Salvant E, Gaete K, Biondi M, Moloo B, Goldstein A, Avery S, Ma K, Pietraszek A, Wootton SK, Alhaboub A, Martin B, Mubareka S, Corredor J, Sultana A, Adeekoa A, Budylowski P, Ostrowski M, Chao J, Nagy E, Kozak R |
Journal of Virology | 2025 |
|
Advances in Surrogate Neutralization Tests for High-Throughput Screening and the Point-of-Care
Streif S, Baeumner AJ |
Analytical Chemistry | 2025 |
|
Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes.
Jin M, Hassan Z, Li Z, Liu Y, Marakhovskaia A, Wong AHM, Forman A, Nitz M, Gilbert M, Yu H, Chen X, Rini JM |
Nature communications | 2025 |
|
Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection.
Odo T, Haun BK, Williams CA, Ball A, To A, Wong TAS, Ching L, Nakano E, Van Ry A, Pessaint L, Andersen H, Donini O, Nerurkar VR, Lehrer AT |
COVID | 2025 |
|
Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.
Coleman BL, Robertson NM, Harrison RA, Valiquette L, Langley JM, Muller MP, Cooper CL, Nadarajah J, Powis J, Arnoldo S, Smieja M, Vanderkooi OG, Qi F, Colwill K, Gingras AC, McGeer A |
Epidemiology and infection | 2025 |
|
Detection methods and dynamic characteristics of specific antibodies in patients with COVID-19: A review of the early literature.
Xu J, Chen J, Wen F, Liu K, Chen Y |
Heliyon | 2024 |
|
Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study.
Enilama O, Yau K, Er L, Atiquzzaman M, Oliver MJ, Romney MG, Leis JA, Abe KT, Qi F, Colwill K, Gingras AC, Hladunewich MA, Levin A |
Canadian Journal of Kidney Health and Disease | 2024 |
|
tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains.
Ivanusic D, Maier J, Icli S, Falcone V, Bernauer H, Bannert N |
iScience | 2024 |
|
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19
Trombetta CM, Accardi G, Aiello A, Calabrò A, Caruso C, Ligotti ME, Marchi S, Montomoli E, Neto MM, Temperton N, Candore G |
Immunity & ageing : I & A | 2024 |
|
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease
Woelfel S, Dütschler J, Junker D, König M, Leinenkugel G, Graf N, Krieger C, Truniger S, Franke A, Koller S, Metzger-Peter K, Oberholzer M, Frei N, Geissler N, Schaub P, Albrich WC, Friedrich M, Niess JH, Schneiderhan-Marra N, Dulovic A, Korte W, Bürgi JJ, Brand S |
Human vaccines | 2024 |
|
Characterization of biotinylated human ACE2 and SARS-CoV-2 Omicron BA.4/5 spike protein reference materials
Stocks BB, Thibeault MP, L\u2019Abbé D, Umer M, Liu Y, Stuible M, Durocher Y, Melanson JE |
Analytical and Bioanalytical Chemistry | 2024 |
|
Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
Eliadis P, Mais A, Papazisis A, Loxa EK, Dimitriadis A, Sarrigeorgiou I, Backovic M, Agallou M, Zouridakis M, Karagouni E, Lazaridis K, Mamalaki A, Lymberi P |
Vaccines | 2024 |
|
The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect
Cin D, Soguksu P, Oren MM, Ozgulnar N, Agacfidan A, Mese S |
Viruses | 2024 |
|
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice
Hurst JR, Naghibosadat M, Budowski P, Liu J, Samaan P, Budiman F, Kurtesi A, Qi F, Menon H, Krishnan R, Abioye J, Gingras AC, Ostrowski M, Orozco NM, Kozak RA |
PLOS ONE | 2024 |
|
Direct detection of 4-dimensions of SARS-CoV-2: infection (vRNA), infectivity (antigen), binding antibody, and functional neutralizing antibody in saliva
Mohammadi A, Chiang S, Li F, Wei F, Lau CS, Aziz M, Ibarrondo FJ, Fulcher JA, Yang OO, Chia D, Kim Y, Wong DT |
Scientific Reports | 2024 |
|
An Evaluation of the Cellular and Humoral Response of a Multi-Epitope Vaccine Candidate Against COVID-19 with Different Alum Adjuvants
Vega Rojas LJ, Ruíz-Manzano RA, Velasco-Elizondo MA, Carbajo-Mata MA, Hernández-Silva DJ, Rocha-Solache M, Hernández J, Pérez-Serrano RM, Zaldívar-Lelo de Larrea G, García-Gasca T, Mosqueda J |
Pathogens | 2024 |
|
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay
Ali DW, Bartlett ML, Heger CD, Ramirez F, Johnson L, Schully KL, Laing ED, Wang W, Weiss CD, Goguet E, Broder CC, Richard SA, Epsi NJ, Agan B, Tribble D, Simons MP, Burgess TH, Mitre E, Pollett S, Smith DR |
npj Viruses | 2024 |
|
Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients
Ferreira VH, Hu Q, Kurtesi A, Solera JT, Ierullo M, Gingras AC, Kumar D, Humar A |
American Journal of Transplantation | 2023 |
|
Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera
Ahn MJ, Kang JA, Hong SM, Lee KS, Kim DH, Song D, Jeong DG |
Biochemical and Biophysical Research Communications | 2023 |
|
A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
Lu Y, Li Q, Fan H, Liao C, Zhang J, Hu H, Yi H, Peng Y, Lu J, Chen Z |
International Journal of Nanomedicine | 2023 |
|
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers
Aguilar R, Li X, Crowell CS, Burrell T, Vidal M, Rubio R, Jiménez A, Hernández-Luis P, Hofmann D, Mijočević H, Jeske S, Christa C, D'Ippolito E, Lingor P, Knolle PA, Roggendorf H, Priller A, Yazici S, Carolis C, Mayor A, Schreiner P, Poppert H, Beyer H, Schambeck SE, Izquierdo L, Tortajada M, Angulo A, Soutschek E, Engel P, Garcia-Basteiro A, Busch DH, Moncunill G, Protzer U, Dobaño C, Gerhard M |
Microbiology spectrum | 2023 |
|
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study
Mestiri S, Merhi M, Inchakalody VP, Taib N, Smatti MK, Ahmad F, Raza A, Ali FH, Hydrose S, Fernandes Q, Ansari AW, Sahir F, Al-Zaidan L, Jalis M, Ghoul M, Allahverdi N, Al Homsi MU, Uddin S, Jeremijenko AM, Nimir M, Abu-Raddad LJ, Abid FB, Zaqout A, Alfheid SR, Saqr HM, Omrani AS, Hssain AA, Al Maslamani M, Yassine HM, Dermime S |
Frontiers in immunology | 2023 |
|
The SpACE-CCM: A facile and versatile cell culture medium-based biosensor for detection of SARS-CoV-2 spike-ACE2 interaction
Ham Y, Cho NC, Kim D, Kim JH, Jo MJ, Jeong MS, Pak BY, Lee S, Lee MK, Chi SW, Kim TD, Jeong NC, Cho S |
Biosensors & bioelectronics | 2023 |
|
Performance Evaluation of RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test for the Rapid Detection of SARS-CoV-2 Antibodies
Kim HN, Yoon J, Jang WS, Lim CS |
Diagnostics | 2023 |
|
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Gattinger P, Ohradanova-Repic A, Valenta R |
International journal of molecular sciences | 2023 |
|
Diagnostic TR-FRET assays for detection of antibodies in patient samples
Yue H, Nowak RP, Overwijn D, Payne NC, Fischinger S, Atyeo C, Lam EC, St. Denis K, Brais LK, Konishi Y, Sklavenitis-Pistofidis R, Baden LR, Nilles EJ, Karlson EW, Yu XG, Li JZ, Woolley AE, Ghobrial IM, Meyerhardt JA, Balazs AB, Alter G, Mazitschek R, Fischer ES |
2023 | |
|
Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses
Kassardjian A, Sun E, Sookhoo J, Muthuraman K, Boligan KF, Kucharska I, Rujas E, Jetha A, Branch DR, Babiuk S, Barber B, Julien JP |
Cell Reports | 2023 |
|
Cell-Free Dot Blot: an Ultra-Low-Cost and Practical Immunoassay Platform for Detection of Anti-SARS-CoV-2 Antibodies in Human and Animal Sera
Norouzi M, Truong T, Jaenes K, Warner BM, Vendramelli R, Tierney K, Kobasa D, Tailor N, Plant P, dos Santos C, Babiuk S, Ambagala A, Pardee K |
Microbiology spectrum | 2023 |
|
Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates
Mendoza-Ramírez NJ, García-Cordero J, Martínez-Frías SP, Roa-Velázquez D, Luria-Pérez R, Bustos-Arriaga J, Hernández-Lopez J, Cabello-Gutiérrez C, Zúñiga-Ramos JA, Morales-Ríos E, Pérez-Tapia SM, Espinosa-Cantellano M, Cedillo-Barrón L |
Human vaccines | 2023 |
|
Inhibition of Exchange Proteins Directly Activated by cAMP (EPAC) as a Strategy for Broad-Spectrum Antiviral Development.
Boulton S, Crupi MJF, Singh S, Carter-Timofte ME, Azad T, Organ BC, He X, Gill R, Neault S, Jamieson T, Dave J, Kurmasheva N, Austin B, Petryk J, Singaravelu R, Huang BZ, Franco N, Babu K, Parks RJ, Ilkow CS, Olagnier D, Bell JC |
The Journal of biological chemistry | 2023 |
|
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Dong T, Wang M, Liu J, Ma P, Pang S, Liu W, Liu A |
Chemical Science | 2023 |
|
SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
Kim E, Khan MS, Ferrari A, Huang S, Sammartino JC, Percivalle E, Kenniston TW, Cassaniti I, Baldanti F, Gambotto A |
Microbiology spectrum | 2023 |
|
An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement
Rocha VP, Quadros HC, Fernandes AM, Gonçalves LP, Badaró RJ, Soares MB, Machado BA |
Viruses | 2023 |
|
Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals
Whelan M, Galipeau Y, White-Al Habeeb N, Konforte D, Abou El Hassan M, Booth RA, Arnold C, Langlois MA, Pelchat M |
Open Forum Infectious Diseases | 2023 |
|
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
Lin YC, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O\u2019Brien SF, Drews SJ |
Microbiology spectrum | 2023 |
|
The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2.
Chen HF, Wang WJ, Chen CY, Chang WC, Hsueh PR, Peng SL, Wu CS, Chen Y, Huang HY, Shen WJ, Wang SC, Hung MC |
eLife | 2023 |
|
Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada
Costiniuk CT, Singer J, Lee T, Galipeau Y, McCluskie PS, Arnold C, Langlois MA, Needham J, Jenabian MA, Burchell AN, Samji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DH, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Vulesevic B, Lebouché B, Angel JB, Routy JP, Cooper CL, Anis AH |
AIDS | 2023 |
|
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
Matveev VA, Mihelic EZ, Benko E, Budylowski P, Grocott S, Lee T, Korosec CS, Colwill K, Stephenson H, Law R, Ward LA, Sheikh-Mohamed S, Mailhot G, Delgado-Brand M, Pasculescu A, Wang JH, Qi F, Tursun T, Kardava L, Chau S, Samaan P, Imran A, Copertino DC Jr, Chao G, Choi Y, Reinhard RJ, Kaul R, Heffernan JM, Jones RB, Chun TW, Moir S, Singer J, Gommerman J, Gingras AC, Kovacs C, Ostrowski M |
iScience | 2023 |
|
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
Cantoni D, Wilkie C, Bentley EM, Mayora-Neto M, Wright E, Scott S, Ray S, Castillo-Olivares J, Heeney JL, Mattiuzzo G, Temperton NJ |
Frontiers in immunology | 2023 |
|
Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV
Matveev VA, Mihelic EZ, Benko E, Budylowski P, Grocott S, Lee T, Korosec CS, Colwill K, Stephenson H, Law R, Ward LA, Sheikh-Mohamed S, Mailhot G, Delgado-Brand M, Pasculescu A, Wang JH, Qi F, Tursun T, Kardava L, Chau S, Samaan P, Imran A, Copertino DC Jr, Chao G, Choi Y, Reinhard RJ, Kaul R, Heffernan JM, Jones RB, Chun TW, Moir S, Singer J, Gommerman J, Gingras AC, Kovacs C, Ostrowski M |
2023 | |
|
Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection
Wang L, Patrone PN, Kearsley AJ, Izac JR, Gaigalas AK, Prostko JC, Kwon HJ, Tang W, Kosikova M, Xie H, Tian L, Elsheikh EB, Kwee EJ, Kemp T, Jochum S, Thornburg N, McDonald LC, Gundlapalli AV, Lin-Gibson S |
International journal of molecular sciences | 2023 |
|
The relationship between the number of COVID-19 vaccines and infection with Omicron ACE2 inhibition at 18-months post initial vaccination in an adult cohort of Canadian paramedics
Yap J, Kayda I, Asamoah-Boaheng M, Haig S, Kirkham T, Cheskes S, Demers P, Goldfarb D, Grunau BE |
2023 | |
|
Modulating SARS-CoV-2 Spike Protein Reactivity through Moderate Electric Fields: A Pathway to Innovative Therapies
Nguyen TH, Wang H, Chen LY, Echtermeyer D, Pliquett U |
ACS Omega | 2023 |
|
Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs.
Mosqueda J, Hernández-Silva DJ, Vega-López MA, Vega-Rojas LJ, Beltrán R, Velasco-Elizondo A, Ramírez-Estudillo MDC, Fragoso-Saavedra M, Pérez-Almeida C, Hernández J, Melgoza-González EA, Hinojosa-Trujillo D, Mercado-Uriostegui MÁ, Mejía-López AS, Rivera-Ballesteros C, García-Gasca T |
Frontiers in immunology | 2023 |
|
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
Walmsley S, Nabipoor M, Lovblom LE, Ravindran R, Colwill K, McGeer A, Dayam RM, Manase D, Gingras AC |
Human vaccines | 2023 |
|
Direct Detection of 4-Dimensions of SARS-CoV-2: Infection (vRNA), Infectivity (Antigen), Binding Antibody, and Functional Neutralizing Antibody in Saliva
Mohammadi A, Chiang S, Li F, Wei F, Lau CS, Aziz M, Ibarrondo FJ, Fulcher JA, Yang OO, Chia D, Kim Y, Wong DT |
Research square | 2023 |
|
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients.
Yau K, Tam P, Chan CT, Hu Q, Qi F, Abe KT, Kurtesi A, Jiang Y, Estrada-Codecido J, Brown T, Liu L, Siwakoti A, Leis JA, Levin A, Oliver MJ, Colwill K, Gingras AC, Hladunewich MA |
Clinical journal of the American Society of Nephrology : CJASN | 2023 |
|
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseases
Roya Dayam, Jaclyn C Law, Rogier Goetgebuer, Gary Y.C. Chao, Kento T Abe, Mitchell Sutton, Naomi Finkelstein, Joanne M Stempak, Daniel Pereira, David Croitoru, Lily Acheampong, Saima Rizwan, Klaudia Rymaszewski, Raquel Milgrom, Darshini Ganatra, Nathalia V. Batista, Melanie Girard, Irene Lau, Ryan Law, Michelle W. Cheung, Bhavisha Rathod, Julia Kitaygorodsky, Reuben Samson, Queenie Hu, W Rod Hardy, Nigil Haroon, Robert Inman, Vincent Piguet, Vinod Chandran, Mark S Silverberg, Anne-Claude Gingras, Tania Helen Watts |
JCI Insight | 2022 |
|
Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
S Wang, L Liu, C Wang, Z Wang, X Duan, G Chen, H Zhou, H Shao |
2022 | |
|
Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy
Z Cheng, B Li, Z Zhan, Z Zhao, M Xue, P Zheng, J Lyu, C Hu, J He, R Chen, B Sun |
Clinical Reviews in Allergy & Immunology | 2022 |
|
Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses
A Wisnewski, J Liu, C Lucas, J Klein, A Iwasaki, L Cantley, L Fazen, J Luna, M Slade, C Redlich, P Ho |
PloS one | 2022 |
|
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
J Liu, P Budylowski, R Samson, B Griffin, G Babuadze, B Rathod, K Colwill, J Abioye, J Schwartz, R Law, L Yip, S Ahn, S Chau, M Naghibosadat, Y Arita, Q Hu, F Yue, A Banerjee, W Hardy, K Mossman, S Mubareka, R Kozak, M Pollanen, N Orozco, A Gingras, E Marcusson, M Ostrowski |
Science Advances | 2022 |
|
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
S Drews, Q Hu, R Samson, K Abe, B Rathod, K Colwill, A Gingras, Q Yi, S OBrien, H Mostafa |
Microbiology spectrum | 2022 |
|
A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies
F Pi-Estopiñan, M Pérez, A Fraga, G Bergado, G Díaz, I Orosa, M Díaz, J Solozábal, L Rodríguez, D Garcia-Rivera, C Macías, Y Jerez, A Casadesús, B Fernández-Marrero, E Bermúdez, C Plasencia, B Sánchez, T Hernández |
Vaccine | 2022 |
|
Comparison of the Anti-SARS-CoV-2 Surrogate Neutralization Assays by TECOmedical and DiaPROPH-Med with Samples from Vaccinated and Infected Individuals
L Münsterkötter, M Hollstein, A Hahn, A Kröger, M Schnelle, L Erpenbeck, U Groß, H Frickmann, A Zautner |
Viruses | 2022 |
|
Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD
D Kolesov, M Sinegubova, L Dayanova, I Dolzhikova, I Vorobiev, N Orlova |
Diagnostics | 2022 |
|
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
A Tuite, D Fisman, K Abe, B Rathod, A Pasculescu, K Colwill, A Gingras, Q Yi, S OBrien, S Drews, D Pride |
Microbiology spectrum | 2022 |
|
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
P Tzou, K Tao, S Pond, R Shafer, J Bhattacharya |
PloS one | 2022 |
|
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
K Colwill, Y Galipeau, M Stuible, C Gervais, C Arnold, B Rathod, K Abe, J Wang, A Pasculescu, M Maltseva, L Rocheleau, M Pelchat, M FazelZarandi, M Iskilova, M BarriosRodiles, L Bennett, K Yau, F Cholette, C Mesa, A Li, A Paterson, M Hladunewich, P Goodwin, J Wrana, S Drews, S Mubareka, A McGeer, J Kim, M Langlois, A Gingras, Y Durocher |
IBMS BoneKEy | 2022 |
|
Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts
Adams O, Andrée M, Hermsen D, Lübke N, Timm J, Schaal H, Müller L |
Journal of Virological Methods | 2022 |
|
Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA
Tuells J, Parra-Grande M, Santos-Calle FJ, Montagud AC, Egoavil CM, García-Rivera C, Caballero P, Gabaldón-Bravo EM, Rodríguez-Diaz JC, Hurtado-Sánchez JA |
Human vaccines | 2022 |
|
Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters
Babuadze GG, Fausther-Bovendo H, deLaVega MA, Lillie B, Naghibosadat M, Shahhosseini N, Joyce MA, Saffran HA, Lorne Tyrrell D, Falzarano D, Senthilkumaran C, Christie-Holmes N, Ahn S, Gray-Owen SD, Banerjee A, Mubareka S, Mossman K, Dupont C, Pedersen J, Lafrance MA, Kobinger GP, Kozak R |
npj Vaccines | 2022 |
|
Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273
Grunau B, Golding L, Prusinkiewicz MA, Asamoah-Boaheng M, Armour R, Marquez AC, Jassem AN, Barakauskas V, O\u2019Brien SF, Drews SJ, Haig S, Lavoie PM, Goldfarb DM |
Microbiology spectrum | 2022 |
|
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis
Yau K, Chan CT, Abe KT, Jiang Y, Atiquzzaman M, Mullin SI, Shadowitz E, Liu L, Kostadinovic E, Sukovic T, Gonzalez A, McGrath-Chong ME, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Levin A, Blake PG, Colwill K, Gingras AC, Hladunewich MA |
CMAJ : Canadian Medical Association Journal | 2022 |
|
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
Nantanee R, Aikphaibul P, Jaru-Ampornpan P, Sodsai P, Himananto O, Theerawit T, Sophonphan J, Tovichayathamrong P, Manothummetha K, Laohasereekul T, Hiransuthikul N, Hirankarn N, Puthanakit T |
Vaccine | 2022 |
|
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine
Kumar D, Hu Q, Samson R, Ferreira VH, Hall VG, Ierullo M, Majchrzak\u2010Kita B, Hardy W, Gingras A, Humar A |
American Journal of Transplantation | 2022 |
|
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study
Erdoğan AP, Ekinci F, Akçalı S, Göksel G |
Journal of Infection and Chemotherapy | 2022 |
|
Fatty Acid Synthase inhibitor TVB-3166 prevents S-acylation of the Spike protein of human coronaviruses.
Mekhail K, Lee M, Sugiyama M, Astori A, St-Germain J, Latreille E, Khosraviani N, Wei K, Li Z, Rini J, Lee WL, Antonescu C, Raught B, Fairn GD |
Journal of lipid research | 2022 |
|
Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies.
Wu W, Tan X, Zupancic J, Schardt JS, Desai AA, Smith MD, Zhang J, Xie L, Oo MK, Tessier PM, Fan X |
Analytical Chemistry | 2022 |
|
Différences d’immunogénicité des vaccins anti-SRAS-CoV-2 mRNA-1273 (Moderna) et BNT162b2 (Pfizer-BioNTech) chez les patients dialysés.
Yau K, Chan CT, Abe KT, Jiang Y, Atiquzzaman M, Mullin SI, Shadowitz E, Liu L, Kostadinovic E, Sukovic T, Gonzalez A, McGrath-Chong ME, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Levin A, Blake PG, Colwill K, Gingras AC, Hladunewich MA |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2022 |
|
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021.
Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Robbins NF, Orjuela G, Jenkins C, Conrod V, Yi QL, O'Brien SF, Drews SJ |
Microbiology spectrum | 2022 |
|
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies.
Kim SJ, Yao Z, Marsh MC, Eckert DM, Kay MS, Lyakisheva A, Pasic M, Bansal A, Birnboim C, Jha P, Galipeau Y, Langlois MA, Delgado JC, Elgort MG, Campbell RA, Middleton EA, Stagljar I, Owen SC |
Nature Communications | 2022 |
|
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings.
Ferreira VH, Solera JT, Hu Q, Hall VG, Arbol BG, Rod Hardy W, Samson R, Marinelli T, Ierullo M, Virk AK, Kurtesi A, Mavandadnejad F, Majchrzak-Kita B, Kulasingam V, Gingras AC, Kumar D, Humar A |
Nature Communications | 2022 |
|
Analysis of Factors Affecting Neutralizing Antibody Production after COVID-19 Vaccination Using Newly Developed Rapid Point-of-Care Test
Shim HW, Shin JH, Shin SC, Lee HJ, So KS, Lee SY, Jun JW, Seo JK, Lee HS, Lee SY, Kim SH, Kim SJ, Kim KC, Ryu GH |
Diagnostics | 2022 |
|
Changes Over Time in COVID-19 Incidence, Vaccinations, Serum Spike IgG, and Viral Neutralizing Potential Among Individuals From a North American Gaming Venue: December 2020–August 2021
Wisnewski AV, Cantley L, Campillo Luna J, Liu J, Smith RF, Hager K, Redlich CA |
Journal of Occupational and Environmental Medicine | 2022 |
|
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
Taha Z, Arulanandam R, Maznyi G, Godbout E, Carter-Timofte ME, Kurmasheva N, Reinert LS, Chen A, Crupi MJ, Boulton S, Laroche G, Phan A, Rezaei R, Alluqmani N, Jirovec A, Acal A, Brown EE, Singaravelu R, Petryk J, Idorn M, Potts KG, Todesco H, John C, Mahoney DJ, Ilkow CS, Giguère P, Alain T, Côté M, Paludan SR, Olagnier D, Bell JC, Azad T, Diallo JS |
Molecular Therapy | 2022 |
|
Colorimetric and fluorometric reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for diagnosis of SARS-CoV-2.
Alhamid G, Tombuloglu H, Motabagani D, Motabagani D, Rabaan AA, Unver K, Dorado G, Al-Suhaimi E, Unver T |
Functional & Integrative Genomics | 2022 |
|
Cohort profile: Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
Collins E, Galipeau Y, Arnold C, Bosveld C, Heiskanen A, Keeshan A, Nakka K, Shir-Mohammadi K, St-Denis-Bissonnette F, Tamblyn L, Vranjkovic A, Wood LC, Booth R, Buchan CA, Crawley AM, Little J, McGuinty M, Saginur R, Langlois MA, Cooper CL |
BMJ Open | 2022 |
|
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, Casadevall A |
Clinical microbiology reviews | 2022 |
|
SARS-CoV-2 detection methods: A comprehensive review
Alhamid G, Tombuloglu H, Rabaan AA, Al-Suhaimi E |
Saudi Journal of Biological Sciences | 2022 |
|
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses.
Lin YJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O'Brien SF, Drews SJ |
Microbiology spectrum | 2022 |
|
Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic.
Drews SJ, O'Brien SF |
Viruses | 2022 |
|
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals.
Grunau B, Prusinkiewicz M, Asamoah-Boaheng M, Golding L, Lavoie PM, Petric M, Levett PN, Haig S, Barakauskas V, Karim ME, Jassem AN, Drews SJ, Sediqi S, Goldfarb DM |
Microbiology spectrum | 2022 |
|
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay.
Klüpfel J, Paßreiter S, Rumpf M, Christa C, Holthoff HP, Ungerer M, Lohse M, Knolle P, Protzer U, Elsner M, Seidel M |
Analytical and Bioanalytical Chemistry | 2022 |
|
Humoral Responses in the Omicron Era Following 3-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients
McEvoy CM, Hu Q, Abe KT, Yau K, Oliver MJ, Levin A, Gingras AC, Hladunewich MA, Yuen DA |
Transplantation Direct | 2022 |
|
Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines
Demone J, Maltseva M, Nourimand M, Nasr-Sharif M, Galipeau Y, Alarcon EI, Langlois MA, MacLean AM |
PloS one | 2022 |
|
Development of receptor binding domain-based double-antigen sandwich lateral flow immunoassay for the detection and evaluation of SARS-CoV-2 neutralizing antibody in clinical sera samples compared with the conventional virus neutralization test
Zhang Y, Chen Y, He Y, Li Y, Zhang X, Liang J, He J, Lu S, Gao Z, Xu J, Tang Y |
Talanta | 2022 |
|
A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines
Gomez AM, Babuadze G(, Plourde-Campagna MA, Azizi H, Berger A, Kozak R, de La Vega MA, XIII A, Naghibosadat M, Nepveu-Traversy ME, Ruel J, Kobinger GP |
npj Vaccines | 2022 |
|
Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors
Chan K, Farias AG, Lee H, Guvenc F, Mero P, Brown KR, Ward H, Billmann M, Aulakh K, Astori A, Haider S, Marcon E, Braunschweig U, Pu S, Habsid A, Yan Tong AH, Christie-Holmes N, Budylowski P, Ghalami A, Mubareka S, Maguire F, Banerjee A, Mossman KL, Greenblatt J, Gray-Owen SD, Raught B, Blencowe BJ, Taipale M, Myers C, Moffat J |
Heliyon | 2022 |
|
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivk ML, Lundin K, Karlsen RF, Dahle R, Danielsson K, Thomassen KS, Kro GB, Cox RJ, Zhou F, Langeland N, Aukrust P, Melum E, Åvitsland TL, Wiencke K, Holter JC, Munthe LA, Grødeland G, Andersen JT, Vaage JT, Lund-Johansen F |
npj Vaccines | 2022 |
|
Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
Maltseva M, Galipeau Y, Renner TM, Deschatelets L, Durocher Y, Akache B, Langlois MA |
Human vaccines | 2022 |
|
Pharmacokinetic and Pharmacodynamic Effects of Polyclonal Antibodies against SARS-CoV2 in Mice
Jha A, Doyle-Eisele M, Revelli D, Carnelley T, Barker D, Kodihalli S |
Viruses | 2022 |
|
COVID-19 breakthrough infections in vaccinated participants of the Safety and Efficacy of Preventative COVID Vaccines sub-study
Walmsley S, Ravindran R, Clarke R, Wouters B, Silva A, Gingras AC, Szadkowski L |
2022 | |
|
Epitope-specific antibody responses differentiate COVID-19 outcome and variants of concern
Courtney Voss, Sally Esmail, Xuguang Liu, Michael J Knauer, Suzanne Ackloo, Tomonori Kaneko, Lori E Lowes, Peter J Stogios, Almagul Seitova, Ashley Hutchinson, Farhad Yusifov, Tatiana Skarina, Elena Evdokimova, Peter Loppnau, Pegah Ghiabi, Taraneh Hajian, Shanshan Zhong, Husam Abdoh, Benjamin D Hedley, Vipin Bhayana, Claudio M Martin, Marat Slessarev, Benjamin Chin-Yee, Douglas D. Fraser, Ian Chin-Yee, Shawn Li |
JCI Insight | 2021 |
|
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
Ester Lopez, Ebene R. Haycroft, Amy Adair, Francesca L Mordant, Matthew T O'Neill, Phillip Pymm, Samuel J Redmond, Wen Shi Lee, Nicholas A Gherardin, Adam K Wheatley, Jennifer A. Juno, Kevin John Selva, Samantha K Davis, Samantha L Grimley, Leigh Harty, Damian Purcell, Kanta Subbarao, Dale I. Godfrey, Stephen J Kent, Wai-Hong Tham, Amy W Chung |
JCI Insight | 2021 |
|
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
S Winklmeier, K Eisenhut, D Taskin, H Rübsamen, R Gerhards, C Schneider, PR Wratil, M Stern, P Eichhorn, OT Keppler, M Klein, S Mader, T Kümpfel, E Meinl |
iScience | 2021 |
|
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, RA Booth, Y Durocher, M Cuperlovic-Culf, SA Bennett, AM Crawley, PM Giguère, C Cooper, MA Langlois |
EBioMedicine | 2021 |
|
Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey
LY Leung, S Khan, P Budylowski, Z Li, S Goroshko, Y Liu, S Dong, JR Carlyle, JM Rini, M Ostrowski, GR Ehrhardt |
Frontiers in immunology | 2021 |
|
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
HT Peng, SG Rhind, A Beckett |
2021 | |
|
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
SH Tali, JJ LeBlanc, Z Sadiq, OD Oyewunmi, C Camargo, B Nikpour, N Armanfard, SM Sagan, S Jahanshahi-Anbuhi |
Clinical microbiology reviews | 2021 |
|
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
AM Sholukh, A Fiore-Gartland, ES Ford, MD Miner, YJ Hou, LV Tse, H Kaiser, H Zhu, J Lu, B Madarampalli, A Park, FA Lempp, RS Germain, EL Bossard, JJ Kee, K Diem, AB Stuart, PB Rupert, C Brock, M Buerger, MK Doll, AK Randhawa, L Stamatatos, RK Strong, C McLaughlin, ML Huang, KR Jerome, RS Baric, D Montefiori, L Corey, AM Caliendo |
Journal of clinical microbiology | 2021 |
|
A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples
AE Sancilio, RT DAquila, EM McNally, MP Velez, MG Ison, AR Demonbreun, TW McDade |
Scientific Reports | 2021 |
|
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals
AR Demonbreun, A Sancilio, MP Velez, DT Ryan, R Saber, LA Vaught, NL Reiser, RR Hsieh, RT D'Aquila, B Mustanski, EM McNally, TW McDade |
2021 | |
|
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose
F Fiorino, A Sicuranza, A Ciabattini, A Santoni, G Pastore, M Simoncelli, J Polvere, S Galimberti, S Auddino, C Baratè, F Montagnani, V Sammartano, M Bocchia, D Medaglini |
Biomedicines | 2021 |
|
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
A Ciabattini, G Pastore, F Fiorino, J Polvere, S Lucchesi, E Pettini, S Auddino, I Rancan, M Durante, M Miscia, B Rossetti, M Fabbiani, F Montagnani, D Medaglini |
Frontiers in immunology | 2021 |
|
Resistance of SARS‐CoV ‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020
SJ Drews, KT Abe, Q Hu, R Samson, AC Gingras, K Colwill, B Rathod, J Wang, M FazelZarandi, QL Yi, A Robinson, H Wood, A Tuite, D Fisman, DH Evans, YC Lin, SF O'Brien |
Transfusion | 2021 |
|
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
HA King, MG Joyce, I Lakhal-Naouar, A Ahmed, CM Cincotta, C Subra, KK Peachman, HR Hack, RE Chen, PV Thomas, WH Chen, RS Sankhala, A Hajduczki, EJ Martinez, CE Peterson, WC Chang, M Choe, C Smith, JA Headley, HA Elyard, A Cook, A Anderson, KM Wuertz, M Dong, I Swafford, JB Case, JR Currier, KG Lal, MF Amare, V Dussupt, S Molnar, SP Daye, X Zeng, EK Barkei, K Alfson, HM Staples, R Carrion, SJ Krebs, D Paquin-Proulx, N Karasavvas, VR Polonis, LL Jagodzinski, S Vasan, PT Scott, Y Huang, MS Nair, DD Ho, N de Val, MS Diamond, MG Lewis, M Rao, GR Matyas, GD Gromowski, SA Peel, NL Michael, K Modjarrad, DL Bolton |
Proceedings of the National Academy of Sciences | 2021 |
|
Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks
EN Gallichotte, M Nehring, MC Young, S Pugh, NR Sexton, E Fitzmeyer, KM Quicke, M Richardson, KL Pabilonia, N Ehrhart, BK Fosdick, S VandeWoude, GD Ebel, SW Long |
Microbiology spectrum | 2021 |
|
Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort study
J Taher, C Mighton, S Chowdhary, S Casalino, E Frangione, S Arnoldo, E Bearss, A Binnie, Y Bombard, B Borgundvaag, H Chertkow, M Clausen, L Devine, H Faghfoury, SM Friedman, AC Gingras, Z Khan, T Mazzulli, A McGeer, SL McLeod, TJ Pugh, D Richardson, J Simpson, S Stern, L Strug, A Taher, J Lerner-Ellis |
BMJ Open | 2021 |
|
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
S Saeed, SF OBrien, K Abe, QL Yi, B Rathod, J Wang, M Fazel-Zarandi, A Tuite, D Fisman, H Wood, K Colwill, AC Gingras, SJ Drews, E Ito |
PloS one | 2021 |
|
The biological and clinical significance of emerging SARS-CoV-2 variants
K Tao, PL Tzou, J Nouhin, RK Gupta, T de Oliveira, SL Pond, D Fera, RW Shafer |
Nature Reviews Genetics | 2021 |
|
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis
K Yau, KT Abe, D Naimark, MJ Oliver, J Perl, JA Leis, S Bolotin, V Tran, SI Mullin, E Shadowitz, A Gonzalez, T Sukovic, J Garnham-Takaoka, KQ de Launay, A Takaoka, SE Straus, AJ McGeer, CT Chan, K Colwill, AC Gingras, MA Hladunewich |
2021 | |
|
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
H Altawalah |
Human vaccines | 2021 |
|
Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol
BE Lee, C Sikora, D Faulder, E Risling, LA Little, Y Qiu, T Gao, R Bulat, S Craik, SE Hrudey, A Ohinmaa, CA Estabrooks, AC Gingras, C Charlton, J Kim, H Wood, A Robinson, JN Kanji, N Zelyas, SF OBrien, S Drews, XL Pang |
BMJ Open | 2021 |
|
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding
S Scheiblhofer, S Drothler, W Braun, R Braun, M Boesch, R Weiss |
Vaccine | 2021 |
|
A Bioluminescent Biosensor for Quantifying the Interaction of SARS-CoV-2 and Its Receptor ACE2 in Cells and In Vitro
X Yang, L Liu, Y Hao, E So, SS Emami, D Zhang, Y Gong, PM Sheth, Y Wang |
Viruses | 2021 |
|
Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay
J Papenburg, MP Cheng, R Corsini, C Caya, E Mendoza, K Manguiat, LR Lindsay, H Wood, MA Drebot, A Dibernardo, G Zaharatos, R Bazin, R Gasser, M Benlarbi, G Gendron-Lepage, G Beaudoin-Bussières, J Prévost, A Finzi, M Ndao, CP Yansouni |
Open Forum Infectious Diseases | 2021 |
|
IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers
R Vandergaast, T Carey, S Reiter, C Lathrum, P Lech, C Gnanadurai, M Haselton, J Buehler, R Narjari, L Schnebeck, A Roesler, K Sevola, L Suksanpaisan, A Bexon, S Naik, B Brunton, SC Weaver, G Rafael, S Tran, A Baum, CA Kyratsous, KW Peng, SJ Russell, AL Rasmussen |
mSphere | 2021 |
|
Practical guidance for clinical laboratories for SARS-CoV-2 serology testing
C Charlton, J Kanji, V Tran, J Kus, J Gubbay, C Osiowy, J Robinson, I Sekirov, M Drebot, T Hatchette, DD Stein, N El-Gabalawy, A Lang, L Jiao, P Levet, H Wood, C Therrien, LR Lindsay, M Morshed, J Forbes, A Dibernardo |
2021 | |
|
A human coronavirus evolves antigenically to escape antibody immunity
RT Eguia, KH Crawford, T Stevens-Ayers, L Kelnhofer-Millevolte, AL Greninger, JA Englund, MJ Boeckh, JD Bloom, AS Lauring |
PLoS pathogens | 2021 |
|
A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients
YR Luo, C Yun, I Chakraborty, AH Wu, KL Lynch, YW Tang |
Journal of clinical microbiology | 2021 |
|
Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19
L Tian, EB Elsheikh, PN Patrone, AJ Kearsley, AK Gaigalas, S Inwood, S Lin-Gibson, D Esposito, L Wang |
International journal of molecular sciences | 2021 |
|
A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies
Z Yao, L Drecun, F Aboualizadeh, SJ Kim, Z Li, H Wood, EJ Valcourt, K Manguiat, S Plenderleith, L Yip, X Li, Z Zhong, FY Yue, T Closas, J Snider, J Tomic, SJ Drews, MA Drebot, A McGeer, M Ostrowski, S Mubareka, JM Rini, S Owen, I Stagljar |
Nature Communications | 2021 |
|
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
K Nayak, K Gottimukkala, S Kumar, ES Reddy, VV Edara, R Kauffman, K Floyd, G Mantus, D Savargaonkar, PK Goel, S Arora, M Rahi, CW Davis, S Linderman, J Wrammert, MS Suthar, R Ahmed, A Sharma, K Murali-Krishna, A Chandele |
Virology | 2021 |
|
SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition
T Azad, R Singaravelu, EE Brown, Z Taha, R Rezaei, R Arulanandam, S Boulton, JS Diallo, CS Ilkow, JC Bell |
Biosensors & bioelectronics | 2021 |
|
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
EJ Valcourt, K Manguiat, A Robinson, JC Chen, K Dimitrova, C Philipson, L Lamoureux, E McLachlan, Z Schiffman, MA Drebot, H Wood |
Diagnostic Microbiology and Infectious Disease | 2021 |
|
Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma
C von Rhein, T Scholz, L Henss, R Kronstein-Wiedemann, T Schwarz, RN Rodionov, VM Corman, T Tonn, BS Schnierle |
Journal of Virological Methods | 2021 |
|
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
SK Malladi, R Singh, S Pandey, S Gayathri, K Kanjo, S Ahmed, MS Khan, P Kalita, N Girish, A Upadhyaya, P Reddy, I Pramanick, M Bhasin, S Mani, S Bhattacharyya, J Joseph, K Thankamani, VS Raj, S Dutta, R Singh, G Nadig, R Varadarajan |
The Journal of biological chemistry | 2021 |
|
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
T Perkmann, N Perkmann-Nagele, T Koller, P Mucher, A Radakovics, R Marculescu, M Wolzt, OF Wagner, CJ Binder, H Haslacher, EA Powell |
Microbiology spectrum | 2021 |
|
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
B Akache, TM Renner, A Tran, L Deschatelets, R Dudani, BA Harrison, D Duque, J Haukenfrers, MA Rossotti, F Gaudreault, UD Hemraz, E Lam, S Régnier, W Chen, C Gervais, M Stuible, L Krishnan, Y Durocher, MJ McCluskie |
Scientific Reports | 2021 |
|
Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins
MH Jodaylami, A Djaïleb, P Ricard, É Lavallée, S Cellier-Goethebeur, MF Parker, J Coutu, M Stuible, C Gervais, Y Durocher, F Desautels, MP Cayer, MJ de Grandmont, S Rochette, D Brouard, S Trottier, D Boudreau, JN Pelletier, JF Masson |
Scientific Reports | 2021 |
|
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
EJ Valcourt, K Manguiat, A Robinson, YC Lin, KT Abe, S Mubareka, A Shigayeva, Z Zhong, RC Girardin, A DuPuis, A Payne, K McDonough, Z Wang, R Gasser, A Laumaea, M Benlarbi, J Richard, J Prévost, SP Anand, K Dimitrova, C Phillipson, A McGeer, AC Gingras, C Liang, M Petric, I Sekirov, M Morshed, A Finzi, M Drebot, H Wood, DR Perez |
Microbiology spectrum | 2021 |
|
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, G Beaudoin-Bussières, L Amorim, R Bazin, KC Loftsgard, R Carl, M Chassé, MM Cushing, N Daneman, DV Devine, J Dumaresq, DA Fergusson, C Gabe, MJ Glesby, N Li, Y Liu, A McGeer, N Robitaille, BS Sachais, DC Scales, L Schwartz, N Shehata, AF Turgeon, H Wood, R Zarychanski, A Finzi, D Marceau, A Huang, H Carr, Y Lin, R Lall, C Graham, C Arsenault, V Sales, D Sidhu, M Semret, C Hamm, E Arhanchiague, Z Solh, N Srour, K Soliman, C Yee, V Laroche, S Nahirniak, C Greenaway, M Pai, A Côté, JL Tsang, C Cserti-Gazdewich, D Talbot, S Poulin, R Guimaraes, M Rushton-Marovac, A Langlois, S Ning, A Shih, M Boileau, H Singh, D Ledingham, A Ponnampalam, M Yan, O Prokopchuk-Gauk, A Poirier, G Girouard, K Pavenski, O Drouin, D Harris, M Durand, E Rimmer, D Ovakim, F Ménard, G Cuccarolo, J Carruthers, K Lucier, MC Auclair, M Avram, M Brassard, S Cerro, V Martinez, J Morin, M Saint-Jacques, M Veillette, C Armali, A Kron, D Modi, J Duncan, P Justumus, MS John, G St-Onge, M Hadzi-Tosev, PM Dion, L McGillivary, AV de Moulliac, SA Nyman, S Perilli, PJ Vliet, S Lane, K Pavenski, R Pereira, E Sirotich, J Abelson, S Greene, A Khandelwal, S Thakar, S Longo, SP Anand, M Benlarbi, C Bourassa, M Boutin, J Descôteaux-Dinelle, G Gendron-Lepage, G Goyette, A Laumaea, H Medjahed, J Prévost, J Richard, D Kaufmann, E Brunet-Ratnasingham, N Chaumont, M Drebot, A Robinson, E Mendoza, K Dimitrova, K Manguiat, C Phillipson, M Chan, D Evans, J Lin, L Boyer, M Cloutier, M Drouin, É Ducas, N Dussault, MJ Fournier, P Landy, MÈ Nolin, J Perreault, T Tremblay, I Nazy, F Xie, D Liu, M Wong, G Silverio, K Walkus, M Barton, K Haveman, D Mueller, A Scott, M Moher, G Wood, T Roarty, F Auld, G Carney, V Thomson, R Onell, K Walley, K Donohoe, C Brunk, G Hernandez, T Jacobucci, L Lazosky, P Mann, G Raval, LA Zampieri, M Sekhon, A Wright, N James, G Chang, R Chen, K Deol, J Gantioqui, E Larsen, N Ramdin, M Roche, K Rosinski, L Sham, M Storms, M Gillrie, E Mahe, D Suryanarayan, A Ugarte-Torres, T Robinson, M Gibbs, J Hewsgirard, M Holmes, J McCarthy, M Ody, K Doucette, W Sligl, A Sonpar, K Robertson, J Narayan, L Ravindran, B Stewart, L Zapernick, S Lee, E Sy, A Wong, K Gryzb, S Craddock, D Fuchs, D Myrah, S Sunny, SR Harding, S Kogilwaimath, N Hodgson, D Johnson, S Meier, K Thomson, A Heendeniya, B Houston, Y Kenyan, S Lother, K Olafson, B Rush, T Wuerz, D Solvason, L Albensi, S Alias, N Choi, L Curtis, M Hutmacher, H Kashani, D Lane, N Marten, T Pronyk-Ward, L Rigaux, R Silva, Q Tays, R Naidu, J Mathews, M Mai, V Miceli, L Molson, G Radhakrishnan, L Schaefer, M Haddad, S Landry, R Chernish, R Kruisselbrink, T Liu, J Jeromin, A Siddiqui, C Girolametto, K Krokoszynski, C Main, A Fox-Robichaud, B Rochwerg, E Kruja, D Ellingham, D Sampat, N Tang, D Leto, M Karunakaran, D Ricciuto, K Fusco, T Ghate, H Robinson, I Ball, S Shalhoub, M Slessarev, M Silverman, E Nano, T Bentall, E Campbell, J Kinney, S Parvathy, E Fera, AL Delfa, J Nadarajah, H Solow, E Mendoza, K Engel, D Monaco, L Kononow, S Suntharalingam, M Fralick, L Munshi, S Saeed, O Hajjaj, E Hsu, K Ali, E Duan, G Farjou, L Jenson, M Salib, L Patterson, S Anant, J Ding, J Jomy, P Das, A Geagea, S Ingber, E Owen, A Lostun, T Albano, A Chatterjee, M Giraldo, J Hickey, I Lee, N Okada, N Pasquale, R Ponzielli, M Rahmat, S Sabur, M Schlag, L Aguiar, A Damani, S Hong, M Kokabi, C Perkins, J Cowan, T Giulivi, D MacFadden, J Cyr, A Pecarskie, R Porteous, PO Vedder, I Watpool, P Berardi, L Bustani, A Graver, A Iyengar, M Kisilewicz, J Majewski, M Marovac, R Murthy, K Sharma, M Walcer, Z Chagla, J Cheung, E Duan, F Clarke, K Matic, M Giraldo, J Hickey, I Lee, N Okada, N Pasquale, R Ponzielli, M Rahmat, S Sabur, M Schlag, T Carpenter, K Schwartz, P Suthar, A Jiwajee, D Lindsay, A Malik, B Tse, L Matukas, J Ray, S Bell, E Krok, R Guo, S John, V Joshi, J Keen, C Lazongas, J Ostro, K Shore, J Wang, J Choi, P Nallapati, T Irwin, V Wang, P Sheldrake, N Adhikari, H Wunsch, J Bailey, H Meirovich, C Colavecchia, E Kahwash, S Sud, M Romano, B Coburn, LD Sorbo, J Granton, S Husain, J Pendergrast, A Sharkawy, L Wilcox, S Saeed, O Hajjaj, M Kulikova, S Massin, W Kennette, I Mazzetti, K Naccarato, G Park, A Pennetti, C Primeau, C Vilag, Y Lapointe, AS Lemay, E Duceppe, B Rioux-Massé, C Tremblay, P Arlotto, C Bouchard, S Matte, M Messier-Peet, CL Francoeur, F Lauzier, G Leblanc, D Bellemare, È Cloutier, O Costerousse, ÉC Chénard, R Daher, M Daigle, S Grenier, G Guilbeault, MP Rioux, M St-Onge, A Tremblay, B Beaudoin, L Lanthier, P Larrivée, PA Morin, É Carbonneau, R Lacasse, J Autmizguine, I Boucoiran, GD Pont-Thibodeau, AL Haye, V Lague, K Léveillé, C Quach-Thanh, G Émériaud, P Jouvet, É Haddad, C Turgeon-Provost, S Fox, D Baldé, L Ménard, S Morissette, M Schnorr-Meloche, AA Turcotte, C Vallée, S Castonguay, T Nguyen, N Rivest, M Roussos, E Simoneau, A Belecciu, MH Bouchard, E Daviau, C Martin, N Sabourin, S Tremblay, É Gagné, NL Gagné, J Larouche, V Larouche, V Tremblay, V Tremblay, P Blanchette, D Claveau, M Lamarre, D Tapps, M Albert, A Duca, JM Leduc, JS Boudreault-Pedneault, A Barsalou, S Deschênes-Dion, S Ibrahim, S Ridyard, J Rousseau, S Ahern, MP Arsenault, SF Dufresne, L Mollica, HT Wang, S Beau, D Beaupré, M Dégarie, I Delorme, M Farkas, MO Gratton, A Guertin, G Jalbert, M Meilleur, CR Labrecque, É Santos, JT Lu, J Auger, MC Lessard, L Mardini, Y Pesant, L Delves, L Delves, S Denault, S Grigorova, M Lambert, N Langille, C Langlois, C Rock, Y Sardin-Laframboise, P Archambault, J Bélanger-Pelletier, E Duquet-Deblois, V Dupuis-Picard, Y Hamelin, S Leduc, M Richard, M Fortin, P Gervais, MÈ Boulay, C Ferland, J Guertin, J Lepage, A Roy, S Assouline, S Caplan, L Kong, C Canticas, C Mayhew, J Ouedraogo, TS Tep, G Batist, M Cheng, M Klein, N Kronfli, P Pelletier, S Qureshi, D Vinh, R Dziarmaga, H Peiris, K Proulx-Boucher, J Roger, MA Rothschild, CY Yuen, S Barkati, JP Routy, S Sinanan-Pelletier, R LeBlanc, E St-Hilaire, P Thibeault, K Morin, G Caissie, JC Collette, L Daigle, M Daigle, B Gendron, N Godin, A Lapointe, G Moreau, L Ouellette-Bernier, J Rockburn, B Sonier-Ferguson, C Wilson, R DeSimone, G Ellsworth, R Fry, N Goss, R Gulick, C Vaamonde, T Wilkin, C Arar, J Berardi, D Chen, C Garcia-Miller, A Goldbach, L Gripp, D Hayden, K Kane, J Li, KA Marcelin, C Megill, M Nelson, A Paguntalan, G Raab, G Resso, R Rosario, N Rossen, S Tamura, E Zhao, C Goss, Y Kim, E Patel, S Paul, T Romero, N ElBadri, L Flores, T Sandoval, S Kapadia, L Vasovic, SK Griffiths, D Alvarado, F Goudy, M Lewis, M Loizou, R Louie, C Pambrun, S Torrance, S Drews, J McManus, O Cuevas, W Lafresne, P Ruoso, C Shin, T Steed, R Ward, I Allard, M Germain, S Girard, É Parent, CM Pigeon, ME Lopes, M Pêcego, N Rosario, CA da Costa Silva, T Oliveira, MC Lopes, S Mateos, L Hall, S Paradiso, D Strauss, DM Arnold |
Nature Medicine | 2021 |
|
Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
I Sekirov, M Petric, E Carruthers, D Lawrence, T Pidduck, J Kustra, J Laley, MK Lee, N Chahil, A Mak, PN Levett, E Mendoza, H Wood, M Drebot, M Krajden, M Morshed |
2021 | |
|
Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison
F Cholette, C Mesa, A Harris, H Ellis, K Cachero, P Lacap, Y Galipeau, MA Langlois, AC Gingras, CP Yansouni, J Papenburg, MP Cheng, P Chakraborty, DR Stein, PV Caeseele, S Bartlett, M Krajden, D Goldfarb, A McGeer, C Osiowy, C Hankins, B Mazer, M Drebot, J Kim, GK Nasrallah |
PloS one | 2021 |
|
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
TS Fulford, H Van, NA Gherardin, S Zheng, M Ciula, HE Drummer, S Redmond, HX Tan, I Boo, RJ Center, F Li, SL Grimley, BD Wines, TH Nguyen, FL Mordant, P Ellenberg, LC Rowntree, L Kedzierski, AC Cheng, DL Doolan, G Matthews, K Bond, PM Hogarth, Z McQuilten, K Subbarao, K Kedzierska, JA Juno, AK Wheatley, SJ Kent, DA Williamson, DF Purcell, DA Anderson, DI Godfrey |
EBioMedicine | 2021 |
|
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine: Secondary Analysis of a Randomized Trial
D Kumar, VH Ferreira, VG Hall, Q Hu, R Samson, T Ku, M Ierullo, B Majchrzak-Kita, G Tomlinson, AC Gingras, A Humar |
Annals of internal medicine | 2021 |
|
A novel competition ELISA for the rapid quantification of SARS‐CoV ‐2 neutralizing antibodies in convalescent plasma
E Wouters, C Verbrugghe, R Devloo, I Debruyne, DD Clippel, LV Heddegem, KV Asch, VV Gaver, M Vanbrabant, A Muylaert, V Compernolle, HB Feys |
Transfusion | 2021 |
|
Antigenic characterization of influenza and SARS-CoV-2 viruses
Y Wang, CY Tang, XF Wan |
Analytical and Bioanalytical Chemistry | 2021 |
|
Overview of Neutralizing Antibodies and Their Potential in COVID-19
JJ Morales-Núñez, JF Muñoz-Valle, PC Torres-Hernández, J Hernández-Bello |
Human vaccines | 2021 |
|
Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects
J Zhang, S Xing, D Liang, W Hu, C Ke, J He, R Yuan, Y Huang, Y Li, D Liu, X Zhang, L Li, J Lin, W Li, X Teng, Y Liu, W Wen, Q Kang, D Wang, W Liu, J Xu |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay
AO Shalash, A Azuar, HY Madge, N Modhiran, AA Amarilla, B Liang, AA Khromykh, D Watterson, PR Young, I Toth, M Skwarczynski |
Human vaccines | 2021 |
|
Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
N Duarte, M Yanes-Lane, R Arora, N Bobrovitz, M Liu, M Bego, T Yan, C Cao, C Gurry, C Hankins, M Cheng, A Gingras, B Mazer, J Papenburg, M Langlois |
Open Forum Infectious Diseases | 2021 |
|
Advances in Neutralization Assays for SARS‐CoV‐2
Lu Y, Wang J, Li Q, Hu H, Lu J, Chen Z |
Scandinavian Journal of Immunology | 2021 |
|
Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies
Esmail S, Knauer MJ, Abdoh H, Voss C, Chin-Yee B, Stogios P, Seitova A, Hutchinson A, Yusifov F, Skarina T, Evdokimova E, Ackloo S, Lowes L, Hedley BD, Bhayana V, Chin-Yee I, Li SS |
2021 | |
|
SPEEDS: A portable serological testing platform for rapid electrochemical detection of SARS-CoV-2 antibodies
Peng R, Pan Y, Li Z, Qin Z, Rini JM, Liu X |
Biosensors & bioelectronics | 2021 |
|
Track-etched membrane microplate and smartphone immunosensing for SARS-CoV-2 neutralizing antibody
Wang C, Wu Z, Liu B, Zhang P, Lu J, Li J, Zou P, Li T, Fu Y, Chen R, Zhang L, Fu Q, Li C |
Biosensors & bioelectronics | 2021 |
|
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
B Isho, KT Abe, M Zuo, AJ Jamal, B Rathod, JH Wang, Z Li, G Chao, OL Rojas, YM Bang, A Pu, N Christie-Holmes, C Gervais, D Ceccarelli, P Samavarchi-Tehrani, F Guvenc, P Budylowski, A Li, A Paterson, FY Yue, LM Marin, L Caldwell, JL Wrana, K Colwill, F Sicheri, S Mubareka, SD Gray-Owen, SJ Drews, WL Siqueira, M Barrios-Rodiles, M Ostrowski, JM Rini, Y Durocher, AJ McGeer, JL Gommerman, AC Gingras |
Science Immunology | 2020 |
|
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois |
Frontiers in immunology | 2020 |
|
Contrasting effects of linezolid on healthy and dysfunctional human neutrophils: reducing C5a-induced injury
SJ Evans, AE Roberts, AC Morris, AJ Simpson, LG Harris, D Mack, RE Jenkins, TS Wilkinson |
Scientific Reports | 2020 |
|
Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile
JC Law, WH Koh, P Budylowski, J Lin, FY Yue, KT Abe, B Rathod, M Girard, Z Li, JM Rini, S Mubareka, A McGeer, AK Chan, AC Gingras, TH Watts, MA Ostrowski |
Journal of immunology (Baltimore, Md. : 1950) | 2020 |
|
Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
D Focosi, F Maggi, P Mazzetti, M Pistello |
Reviews in Medical Virology | 2020 |
|
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
DS Khoury, AK Wheatley, MD Ramuta, A Reynaldi, D Cromer, K Subbarao, DH OConnor, SJ Kent, MP Davenport |
Nature Reviews Immunology | 2020 |
|
A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19
N Cimolai |
2020 |
